Icanic Brands Competitors

Abacus Health Products (OTCMKTS:ABAHF) and Icanic Brands (OTCMKTS:ICNAF) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends.

Analyst Recommendations

This is a summary of current recommendations for Abacus Health Products and Icanic Brands, as provided by MarketBeat.com.

Profitability

This table compares Abacus Health Products and Icanic Brands' net margins, return on equity and return on assets.

Valuation & Earnings

This table compares Abacus Health Products and Icanic Brands' revenue, earnings per share and valuation.

Acreage (OTCMKTS:ACRGF) and Icanic Brands (OTCMKTS:ICNAF) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends.

Analyst Recommendations

This is a summary of current recommendations for Acreage and Icanic Brands, as provided by MarketBeat.com.

Acreage currently has a consensus price target of $8.4333, indicating a potential upside of 204.45%. Given Acreage's higher possible upside, research analysts clearly believe Acreage is more favorable than Icanic Brands.

Profitability

This table compares Acreage and Icanic Brands' net margins, return on equity and return on assets.

Valuation & Earnings

This table compares Acreage and Icanic Brands' revenue, earnings per share and valuation.

Summary

Acreage beats Icanic Brands on 2 of the 2 factors compared between the two stocks.

Icanic Brands (OTCMKTS:ICNAF) and Applied Biosciences (OTCMKTS:APPB) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, earnings, risk, profitability and valuation.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Icanic Brands and Applied Biosciences, as reported by MarketBeat.

Profitability

This table compares Icanic Brands and Applied Biosciences' net margins, return on equity and return on assets.

Valuation and Earnings

This table compares Icanic Brands and Applied Biosciences' top-line revenue, earnings per share (EPS) and valuation.

Icanic Brands (OTCMKTS:ICNAF) and Ayr Strategies (OTCMKTS:AYRSF) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, earnings, risk, profitability and valuation.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Icanic Brands and Ayr Strategies, as reported by MarketBeat.

Ayr Strategies has a consensus target price of $34.8571, indicating a potential upside of 63.96%. Given Ayr Strategies' higher possible upside, analysts plainly believe Ayr Strategies is more favorable than Icanic Brands.

Profitability

This table compares Icanic Brands and Ayr Strategies' net margins, return on equity and return on assets.

Valuation and Earnings

This table compares Icanic Brands and Ayr Strategies' top-line revenue, earnings per share (EPS) and valuation.

Summary

Ayr Strategies beats Icanic Brands on 2 of the 2 factors compared between the two stocks.

Icanic Brands (OTCMKTS:ICNAF) and Can B (NASDAQ:CANB) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, earnings, risk, profitability and valuation.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Icanic Brands and Can B, as reported by MarketBeat.

Profitability

This table compares Icanic Brands and Can B's net margins, return on equity and return on assets.

Valuation and Earnings

This table compares Icanic Brands and Can B's top-line revenue, earnings per share (EPS) and valuation.

Icanic Brands (OTCMKTS:ICNAF) and Cansortium (OTCMKTS:CNTMF) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, earnings, risk, profitability and valuation.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Icanic Brands and Cansortium, as reported by MarketBeat.

Cansortium has a consensus target price of $1.20, indicating a potential upside of 11.11%. Given Cansortium's higher possible upside, analysts plainly believe Cansortium is more favorable than Icanic Brands.

Profitability

This table compares Icanic Brands and Cansortium's net margins, return on equity and return on assets.

Valuation and Earnings

This table compares Icanic Brands and Cansortium's top-line revenue, earnings per share (EPS) and valuation.

Summary

Cansortium beats Icanic Brands on 2 of the 2 factors compared between the two stocks.